Cost Effectiveness of Recombinant Zoster Vaccine and Live-Attenuated Vaccine Against Herpes Zoster for Adults Aged 50 and Over in China. [PDF]
Liu L +7 more
europepmc +1 more source
Post-Marketing Surveillance of Adverse Events Following Recombinant Zoster Vaccine - China, 2020-2023. [PDF]
Li Y +9 more
europepmc +1 more source
Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USA. [PDF]
Mayer SE +22 more
europepmc +1 more source
The Effectiveness of Recombinant Zoster Vaccine: Observations in the Wild
openaire +2 more sources
Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy. [PDF]
Williams LR, Hombach J, Marti M.
europepmc +1 more source
Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy. [PDF]
Winthrop KL +10 more
europepmc +1 more source
Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada. [PDF]
George S +5 more
europepmc +1 more source
Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization [PDF]
Cremer, Thomas +5 more
core
Longitudinal single cell profiling of epitope specific memory CD4+ T cell responses to recombinant zoster vaccine. [PDF]
Wen X +5 more
europepmc +1 more source

